Amedisys Inc. Files Form 8-K Reporting Completion of Hart-Scott-Rodino Antitrust Act Waiting Period

Strategic Insights -

Amedisys Inc., a healthcare company, has filed a Form 8-K report with the U.S. Securities and Exchange Commission on June 21, 2023, disclosing the expiration of the Hart-Scott-Rodino Antitrust Act waiting period for its proposed merger with Option Care Health, Inc. The merger remains subject to customary closing conditions and approval by both companies' stockholders. Amedisys and Option Care Health have filed relevant materials with the SEC, including an Option Care Health registration statement on Form S-4, which includes a preliminary joint proxy statement of the two companies.

Key Takeaways:

  • Amedisys Inc., a healthcare company, has filed a Form 8-K report with the U.S. Securities and Exchange Commission on June 21, 2023.
  • The report discloses the expiration of the Hart-Scott-Rodino Antitrust Act waiting period for the proposed merger with Option Care Health, Inc.
  • The merger remains subject to customary closing conditions, including approval by both companies' stockholders.
  • Amedisys and Option Care Health have filed relevant materials with the SEC, including an Option Care Health registration statement on Form S-4.
  • The proposed transaction is subject to a number of risks and uncertainties, including the potential for delays or termination of the merger.
  • Forward-looking statements included in the Form 8-K report provide insight into the potential benefits and risks of the proposed transaction.

Statistics:

  • June 21, 2023: Date of filing of Form 8-K report with the SEC.
  • June 16, 2023: Date of expiration of the Hart-Scott-Rodino Antitrust Act waiting period.
  • 2023: Year in which the merger was initially announced.
  • May 2023: Month in which the Agreement and Plan of Merger was announced.
  • April 7, 2023: Date of filing of proxy statement for Option Care Health's 2023 annual meeting of stockholders.
  • April 27, 2023: Date of filing of proxy statement for Amedisys' 2023 annual meeting of stockholders.

Sources:

  • U.S. Securities and Exchange Commission
  • Amedisys Inc. Form 8-K report, filed June 21, 2023.
  • Option Care Health registration statement on Form S-4, filed with the SEC.
  • Amedisys Inc. proxy statement for 2023 annual meeting of stockholders, filed with the SEC.
  • Option Care Health proxy statement for 2023 annual meeting of stockholders, filed with the SEC.